Back

Comorbidities as key therapeutic targets in heart failure.

30 August 2021 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Essentials in Heart Failure – 2: Therapeutic Targets Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Ewa Anita Jankowska

Wroclaw Medical University, Wroclaw (Poland)

2 More presentations in this session

Presentation thumbnail
Reduction in recurrent heart failure hospitalisations, cardiovascular and non-cardiovascular mortality: therapeutic targets in heart failure.
Professor O. Chioncel (Bucharest, RO)
Slides Video
Presentation thumbnail
Good quality of life and independence: therapeutic targets in heart failure.
Professor L. Hill (Londonderry, GB)
Slides Video

Access the full session

Session thumbnail
Essentials in Heart Failure – 2: Therapeutic Targets
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0
30 August 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Session
Future outlooks into heart failure management in the cardio-renal-metabolic syndrome
19 May 2025
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources